Starobrat-Hermelin B, Kozielec T
Department of Family Medicine, Pomeranian Medical Academy, Szczecin, Poland.
Magnes Res. 1997 Jun;10(2):149-56.
Children with ADHD are 'a group at risk' as far as their further emotional and social development and educational possibilities are concerned, and the consequences of the lack of an appropriate therapy appears to be serious. Some of these children do not respond to prevailing therapy methods. It is reported that dietetic factors can play a significant role in the etiology of ADHD syndrome, and magnesium deficiency can help in revealing hyperactivity in children. The aim of our work was to assess the influence of magnesium supplementation on hyperactivity in patients with ADHD. The examination comprised 50 hyperactive children, aged 7-12 years, who fulfilled DSM IV criteria for ADHD syndrome, with recognized deficiency of magnesium in the blood (blood serum and red blood cells) and in hair using atomic absorption spectroscopy. In the period of 6 months those examined regularly took magnesium preparations in a dose of about 200 mg/day. 30 of those examined with ADHD showed coexisting disorders specific to developmental age, and 20 of them showed disruptive behaviour. The control group consisted of 25 children with ADHD and magnesium deficiency, who were treated in a standard way, without magnesium preparations. 15 members of this group showed coexisting disorders specific for developmental age, and 10 members showed disruptive behaviour. Hyperactivity was assessed with the aid of psychometric scales: the Conners Rating Scale for Parents and Teachers, Wender's Scale of Behavior and the Quotient of Development to Freedom from Distractibility. In the group of children given 6 months of magnesium supplementation, independently of other mental disorders coexisting with hyperactivity, an increase in magnesium contents in hair and a significant decrease of hyperactivity of those examined has been achieved, compared to their clinical state before supplementation and compared to the control group which had not been treated with magnesium.
就多动症儿童的进一步情感和社交发展以及教育前景而言,他们是“高危群体”,而缺乏适当治疗的后果似乎很严重。其中一些儿童对现行治疗方法没有反应。据报道,饮食因素在多动症综合征的病因中可能起重要作用,镁缺乏有助于揭示儿童的多动症状。我们这项研究的目的是评估补充镁对多动症患者多动症状的影响。该检查包括50名7至12岁的多动儿童,他们符合多动症综合征的DSM-IV标准,通过原子吸收光谱法确认血液(血清和红细胞)及头发中镁缺乏。在6个月期间,这些受检者定期服用剂量约为200毫克/天的镁制剂。30名患有多动症的受检者存在发育年龄特有的共存障碍,其中20名表现出破坏性行为。对照组由25名患有多动症且镁缺乏的儿童组成,他们接受标准治疗,未服用镁制剂。该组15名成员存在发育年龄特有的共存障碍,10名成员表现出破坏性行为。借助心理测量量表对多动症状进行评估:父母和教师版康纳斯评定量表、文德行为量表以及注意力分散度发展商数。在接受6个月镁补充治疗的儿童组中,无论与多动症状共存的其他精神障碍如何,与补充前的临床状态以及未接受镁治疗的对照组相比,头发中的镁含量增加,受检者的多动症状显著减轻。